The United States Court of Federal Claims recently upheld a decision denying compensation for a child's alleged vaccine-related injury. The case, TAGUACTA v. SECRETARY OF HEALTH AND HUMAN SERVICES, involved a claim made by Sophianne and Timothy Taguacta on behalf of their son, B.T., who they alleged suffered from encephalitis after receiving the measles, mumps, and rubella (MMR) vaccine. The ruling impacts families seeking compensation under the National Childhood Vaccine Injury Act.

The court ruled that the Taguactas failed to prove that B.T. suffered from chronic encephalopathy, a necessary condition to qualify for compensation under the Vaccine Act. This decision is significant as it reinforces the stringent requirements for proving vaccine-related injuries and may influence future claims made under the Vaccine Act.

Background

The petitioners, Sophianne and Timothy Taguacta, filed their claim under the National Childhood Vaccine Injury Act, which was enacted in 1986 to provide compensation for vaccine-related injuries and deaths. The Taguactas alleged that their son B.T. developed encephalitis as a result of the MMR vaccine he received at 12 months old. Following a series of medical evaluations and treatments, B.T. was diagnosed with various conditions, but the Chief Special Master ultimately dismissed their claim, stating that B.T. did not suffer from chronic encephalopathy.

The case began in March 2022 when the Taguactas filed their petition with the Office of Special Masters. After a lengthy review process, the Chief Special Master concluded in November 2025 that while B.T. experienced some unusual symptoms, he did not meet the criteria for chronic encephalopathy. This conclusion led the Taguactas to seek a review from the U.S. Court of Federal Claims.

The Ruling

The U.S. Court of Federal Claims, presided over by Judge Loren A. Smith, affirmed the Chief Special Master's decision. The court noted that the petitioners had not provided sufficient evidence to support their claim that B.T. suffered from chronic encephalopathy. The court stated, "The Chief Special Master held that petitioners’ Table claim failed because B.T. did not suffer from chronic encephalopathy." This ruling emphasizes the court's reliance on documented medical evidence over anecdotal claims.

The court also highlighted that B.T.'s medical records showed no persistent symptoms of ataxia or other neurological dysfunction that would support the diagnosis of chronic encephalopathy. The Chief Special Master had found that B.T.'s symptoms did not last for the required six months following his vaccination, which is a crucial factor in establishing a claim under the Vaccine Act.

Impact

This ruling has significant implications for families seeking compensation for vaccine-related injuries. It reinforces the need for robust medical evidence to support claims under the Vaccine Act. The court's decision indicates that anecdotal evidence or personal testimonies may not be sufficient to meet the legal standards required for compensation.

The ruling also serves as a reminder that the Vaccine Act has specific criteria that must be met for a claim to be successful. This case may set a precedent for future claims, emphasizing the importance of thorough documentation and medical evaluations in establishing causation between vaccinations and alleged injuries.

What's Next

The Taguactas have the option to appeal the court's decision, although details regarding any potential appeal were not provided in the court filing. Additionally, there may be related cases pending that could further clarify the standards for proving vaccine-related injuries under the National Childhood Vaccine Injury Act.